Abstract
In this project we intend to develop hybrid compounds through the insertion or supporting of ligands and corresponding metal complexes, having biological activity already verified as antitumor, antioxidant or anti-inflammatory properties, in inorganic (as synthetic clays or mesoporous silica) or organic matrices (as dendrimers). The goal is to enhance its performance as potential pharmaco…